Boston Scientific Corporation, a leading global medical technology company, stated it got approval from the US FDA for the Farawave NAV Ablation Catheter and FDA 510(k) clearance for the Faraview Software, both used in treating paroxysmal atrial...
Alembic Pharmaceuticals Ltd announced that it has obtained approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules, which are used for treating hypertension. The company stated that the USFDA has...
Indian companies supply 40% of the world's generic medicines, showcasing India's important role in global healthcare. Dr. Jitendra Kumar, Managing Director of BIRAC, stated that the biotechnology industry in the country is experiencing impressive...
TuHURA Biosciences, a company in phase 3 of registering immune-oncology, is creating new technologies to tackle resistance to cancer immunotherapy. They have finished the merger with Kintara Therapeutics, Inc. and are now called TuHURA Biosciences...
Krishna Institute of Medical Sciences (KIMS), a hospital chain in Hyderabad, announced that it has signed an agreement with Wipro GE Healthcare to acquire medical technology and services worth up to Rs 700 crore. The memorandum of understanding...
National Institutes of Health (NIH) showed that an mpox vaccine administered to teenagers was safe and produced the same level of antibody response as in adults. Young people are one of the demographics impacted by mpox in the ongoing Clade I mpox...
Get ready to dive deep into the future of packaging at PACK.Nxt! Join us for our 2nd edition, where we'll bring together 400+ delegates and 60+ industry leaders to explore the latest trends in Packaging.
Sanofi and Orano Med, which is a part of the Orano Group and specializes in targeted alphatherapies for cancer treatment, have agreed to collaborate in order to advance the development of advanced radioligand treatments for rare cancers. Sanofi...
Cullinan Therapeutics, Inc., a biopharmaceutical company specializing in developing targeted therapies, confirmed FDA approval for their Investigational New Drug Application for CLN-978. This enables the global phase 1 clinical trial in the US for...
Annovis Bio Inc, based in Malvern, a company in the advanced stages of clinical drug development, revealed on October 10, 2024, the positive results of their meeting with the US Food and Drug Administration regarding transformative treatments for...
, CDSCO.jpg)
.jpg)